Orchid Pharma P/B Ratio

Current P/B Ratio
4.69
High Valuation
Very High - Significant premium, high growth expectations or speculative

Orchid Pharma (ORCHPHARMA) P/B ratio is 4.69 (High), book value per share ₹252.55 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read ORCHPHARMA dividend yield for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 4.69
Current Price ₹989.70
Book Value/Share ₹252.55
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹1,288 Cr
Share Capital ₹51 Cr
Reserves & Surplus ₹1,237 Cr
Outstanding Shares 51,000,000
Book Value per Share ₹252.55

Valuation Signal

Signal Overvalued
Historical Avg 4.28
Historical Range 2.31 - 7.88
Percentile 80.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

ORCHPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Orchid Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 4.69 (High). Explore ORCHPHARMA intrinsic value to estimate fundamental worth using multiple valuation models.

  • Stock appears overvalued with PB of 4.69, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of -0.01

Orchid Pharma P/B Ratio Historical Trend

ORCHPHARMA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Orchid Pharma screener.

ORCHPHARMA Historical P/B Ratio — Book Value Per Share & Year-End Price

Orchid Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 3.92 ₹252.55 ₹989.70 ₹1,288 High
2025 3.05 ₹248.43 ₹758.95 ₹1,267 High
2024 7.88 ₹229.41 ₹1807.05 ₹1,170 High
2023 4.24 ₹168.05 ₹712.50 ₹689 High
2022 2.31 ₹157.8 ₹364.05 ₹647 Moderate

ORCHPHARMA vs Healthcare Peers — P/B Ratio Comparison

Orchid Pharma P/B 4.69 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low